Chemoinformaics analysis of 7-Hydroxycostal, (+)-
| Molecular Weight | 234.339 | nRot | 2 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
| Exact Molecular Weight | 234.162 | nRing | 2 |
| Solubility: LogS | -3.796 | nHRing | 0 |
| Solubility: LogP | 2.482 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 41.3234 |
| nHD | 1 | BPOL | 22.9386 |
| QED | 0.453 |
| Synth | 4.559 |
| Natural Product Likeliness | 2.933 |
| NR-PPAR-gamma | 0.079 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.004 |
| CACO-2 | -4.611 |
| MDCK | 0.000018 |
| BBB | 0.779 |
| PPB | 0.606221 |
| VDSS | 1.221 |
| FU | 0.473413 |
| CYP1A2-inh | 0.045 |
| CYP1A2-sub | 0.717 |
| CYP2c19-inh | 0.211 |
| CYP2c19-sub | 0.723 |
| CYP2c9-inh | 0.13 |
| CYP2c9-sub | 0.223 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.294 |
| CYP3a4-inh | 0.212 |
| CYP3a4-sub | 0.305 |
| CL | 5.497 |
| T12 | 0.143 |
| hERG | 0.006 |
| Ames | 0.806 |
| ROA | 0.195 |
| SkinSen | 0.468 |
| Carcinogencity | 0.941 |
| EI | 0.933 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.681 |
| Antiviral | Yes |
| Prediction | 0.922949 |